drugset / Trial / NCT06273839

A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults

NCT06273839

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking three different forms of tafamidis by mouth.

Timeline

Start
2024-02-27
Primary completion
2024-05-27
Completion
2024-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Tafamidis Unknown 61 mg Oral
Subject Tafamidis Unknown 70 mg Oral

Indications

No indication recorded.